GNH USA

Europe — EMA

Paclitaxel Kabi

Paclitaxel, the active ingredient in Paclitaxel Kabi, is a taxane presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various malignant neoplasms and is administered under…

Request sourcing

1
Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Kabi, is a taxane presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various malignant neoplasms and is administered under the supervision of oncology specialists. GNH USA supplies Paclitaxel Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Paclitaxel Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapeutic agent that interferes with cell growth pathways in solid tumours.

- Breast cancer: improves the overall response rate in combination with anthracycline‑based regimens. - Non‑small cell lung cancer: provides tumour shrink and disease control for patients receiving tax‑​  - Ovarian the       -        -    

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Paclitaxel
Route
Intravenous Use
Manufacturer
Fresenius Kabi Austria Gmbh
Origin
EU

Related products